ICIs may activate T cells to secrete numerous pro-inflammation cytokines to eliminate malignant tumor cells, but at the same time ICIs may stimulate the production of immunosuppressive molecules such as PD-L1, IDO1, and IL4I1, resulting in M2 macrophage polarization and T-cell activity inhibition [86]. The gene discussed is CD274; the disease is cancer.